The Vesiculo–Vacuolar Organelle (VVO): A New Endothelial Cell Permeability Organelle

Journal of Histochemistry and Cytochemistry - Tập 49 Số 4 - Trang 419-431 - 2001
Ann M. Dvořàk1, Dian Feng1
1The Departments of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts

Tóm tắt

A newly defined endothelial cell permeability structure, termed the Vesiculo–Vacuolar organelle (VVO), has been identified in the microvasculature that accompanies tumors, in venules associated with allergic inflammation, and in the endothelia of normal venules. This organelle provides the major route of extravasation of macromolecules at sites of increased vascular permeability induced by vascular permeability factor/vascular endothelial growth factor (VPF/VEGF), serotonin, and histamine in animal models. Continuity of these large sessile structures between the vascular lumen and the extracellular space has been demonstrated in kinetic studies with ultrastructural electron-dense tracers, by direct observation of tilted electron micrographs, and by ultrathin serial sections with three-dimensional computer reconstructions. Ultrastructural enzyme-affinity cytochemical and immunocytochemical studies have identified histamine and VPF/VEGF bound to VVOs in vivo in animal models in which these mediators of permeability are released from mast cells and tumor cells, respectively. The high-affinity receptor for VPF/VEGF, VEGFR-2, was localized to VVOs and their substructural components by pre-embedding ultrastructural immunonanogold and immunoperoxidase techniques. Similar methods were used to localize caveolin and vesicle-associated membrane protein (VAMP) to VVOs and caveolae, indicating a possible commonality of formation and function of VVOs to caveolae.

Từ khóa


Tài liệu tham khảo

Baluk P, 1997, Am J Physiol, 272, L155

10.1007/978-3-0348-9006-9_10

10.1083/jcb.37.2.244

10.1073/pnas.76.12.6439

10.1152/physrev.1996.76.1.1

10.1002/(SICI)1096-9896(199801)184:1<44::AID-PATH984>3.0.CO;2-H

10.1002/(SICI)1096-9896(199801)184:1<53::AID-PATH6>3.0.CO;2-7

10.1126/science.1312256

10.1083/jcb.99.5.1678

10.1002/jlb.59.1.100

Dvorak AM, 1992, Diagnostic Ultrastructural Pathology. I. A Text-Atlas of Case Studies Illustrating the Correlative Clinical-Ultrastructural Pathologic Approach to Diagnosis

Dvorak AM, 1995, Diagnostic Ultrastructural Pathology. II. A Text-Atlas of Case Studies Emphasizing Respiratory and Nervous Systems

Dvorak AM, 1995, Diagnostic Ultrastructural Pathology. III. A Text-Atlas of Case Studies Emphasizing Endocrine and Hematopoietic Systems

10.1177/41.6.8315271

10.1182/blood.V83.12.3600.3600

Dvorak HF, 1995, Am J Pathol, 146, 1029

Dvorak HF, 1979, J Natl Cancer Inst, 62, 1459

Dvorak HF, 1999, Curr Top Microbiol Immunol, 237, 97

Feng D, Flaumenhaft R, Bandeiro–Melo C, Weller PF, Dvorak AM (in press) Ultrastructural localization of vesicle-associated membrane protein(s) to specialized membrane structures in human pericytes, vascular smooth muscle cells, endothelial cells, neutrophils, and eosinophils. J Histochem Cytochem

10.1177/002215540004800412

10.1006/mvre.1999.2207

10.1084/jem.183.5.1981

10.1111/j.1469-7793.1997.747bd.x

10.1084/jem.187.6.903

10.1159/000023944

10.1080/713773925

Ferrara N, 1999, Curr Top Microbiol Immunol, 237, 1

10.1210/edrv.18.1.0287

10.1016/0006-291X(89)92678-8

10.1210/edrv-13-1-18

10.1016/0022-5320(80)90111-2

10.1073/pnas.86.19.7311

10.1016/B978-0-12-508301-0.50012-0

10.1007/s004410051136

10.1083/jcb.100.5.1488

10.1007/BF00206264

10.1006/excr.1993.1001

Hilal SK, 1973, Small Vessel Angiography.

Joris I, 1987, Am J Pathol, 126, 19

Kohn S, 1992, Lab Invest, 67, 596

10.1126/science.2479986

10.1161/01.RES.21.6.833

10.1083/jcb.11.3.607

10.1083/jcb.42.3.647

10.1073/pnas.88.20.9026

10.1080/713773924

10.1080/713773926

10.1083/jcb.129.4.895

10.1113/jphysiol.1996.sp021287

10.1007/978-1-4613-0937-6_1

10.1038/labinvest.3780013

10.1073/pnas.91.8.3014

Predescu SA, 1997, Am J Physiol, 272, H937

10.1177/43.4.7534783

10.1073/pnas.90.16.7533

10.1152/jappl.1985.58.2.315

10.1016/S0002-9440(10)65668-4

10.1242/jcs.108.6.2369

Roberts WG, 1997, Cancer Res, 57, 765

10.1016/0092-8674(92)90143-Z

10.1016/1050-1738(93)90012-U

Schnitzer JE, 1995, Am J Physiol, 268, H48

10.1074/jbc.270.24.14399

10.1126/science.6823562

10.1152/physrev.1983.63.4.1536

10.1083/jcb.64.3.586

10.1016/S0092-8674(00)81402-6

Sundberg C, Nagy JA, Broun LF, Feng D, Manseau EJ, Dvorak AM, Dvorak HF (in press) Glomeruloid vascular malformations follow adenoviral VPF/VEGF164 gene delivery. Am J Pathol

10.1200/JCO.1997.15.2.826

Terman BI, 1991, Oncogene, 6, 1677

10.1016/0006-291X(92)90483-2

10.1177/002215549904700205

Vuckovic M, 1996, J Anat, 188, 361